[From teprotide to captopril. Rational design of ACE inhibitors].
Nemec
Karin
K
Institut für Pharmazeutische Chemie Marie-Curie-Str. 9 60439 Frankfurt. Schubert-Zsilavecz@pharmchem.uni-frankfurt.de
Schubert-Zsilavecz
Manfred
M
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology*; D002216:Captopril / Q000138:chemical synthesis* / Q000494:pharmacology*; D015195:Drug Design; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000737:chemistry / Q000378:metabolism; D013722:Teprotide / Q000138:chemical synthesis* / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril; D013722:Teprotide; D007703:Peptidyl-Dipeptidase A